TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMVT

Immunovant Inc

Healthcare · Biotechnology

34.00$ -1.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IMVT
Line item 2018 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – – 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– – – 0.00 0.01 0.01 0.01 0.00 0.00 0.00
– – – 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00
13.53 – 1.79 1.11 0.78 0.93 1.30 1.54 2.38 2.50
0.15 – 0.19 0.42 0.45 0.49 0.39 0.41 0.51 0.42
13.67 – 0.00 1.38 1.23 1.42 1.69 1.96 2.89 2.92
-13.67 – 0.00 -1.38 -1.23 -1.42 -1.69 -1.96 -2.89 -2.92
0.00 – 0.00 0.01 0.00 0.01 0.10 0.36 – –
-13.67 – 0.00 -1.53 -1.23 -1.43 -1.71 -1.87 -2.72 -2.77
– – 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
-13.67 – 0.00 -1.54 -1.22 -1.43 -1.71 -1.88 -2.73 -2.77
– – 0.00 -1.52 -1.23 -1.43 -1.61 -1.87 -2.72 -2.77

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?